In 2018, expenditures for the pharmaceutical industry worldwide reached around $ 1.2 trillion dollars. This figure is expected to increase by 5 percent to 1.3 trillion dollars in 2019 and to $ 1.5 trillion in the next 5 years.
North America has the largest share with 64.1 percent in the sale of newly produced drugs. This is followed by the European Union (18.1 percent) and Japan (7.1 percent). In terms of country-based expenditures, while the United States stands out first, China and Japan follow. 5 countries with the largest share constitute two-thirds of the world pharmaceutical market, which reached $ 1.2 trillion by 2018. The US is almost half of the world pharmaceutical market.
In Turkey, the pharmaceutical market reached TL 30.9 billion value and 2.3 billion box volume in 2018. The reference pharmaceutical market completed 2018 with a value of TL 21.02 billion, while the box scale sold 0.93 billion boxes. The equivalent pharmaceutical market reached a volume of 9.92 billion TL in 2018 and reached 1.37 billion in the box scale.
In 2018, a total of 307 new products entered the market, all of them in prescription status. Oncology medicines were the most important group of drugs in terms of unit market share, while antibiotics followed.
Oncology and blood products consumption increased in parallel with the recent years, and the consumption of antibiotics and cardiovascular products decreased relatively. However, in Turkey, antibiotic consumption per person is still in first among European countries.
The increase in the number of boxes sold in the previous years, increase in exports, new product trends in the market will continue in 2019, and assuming SSI reimbursement list discounts will not increase in 2019, the sector will grow by 32 to 35 percent, and accordingly it is expected to reach 41 billion TL.